Internazionale Medico Scientifica Mammography Sys

Internazionale Medico Scientifica 3/5/97 Mammography Systems

The above-stated inspection revealed that these devices are adulterated under section 501(h) of the Act, in that the methods used in, and the facilities or controls used for the manufacturing, packing, storage, and installation are not in conformance with the Good Manufacturing Practice (GMP) for Medical Devices Regulations, as specified in Title 21, Code of Federal Regulations (21 CFR), Part 820 as follows:

1. Failure to establish and implement specification control measures to assure that the design basis for the devices is correctly translated into approved specifications, as required by 21 CFR 820.100(a)(1). For example, the validation documentation was not available for the operation of the Giotto [purged word] and [purged word] units; including verification of the software functions with the mammography device.

Your response may be adequate if verified by documentation showing implementation. Your response noted that this deficiency would be completed by mid-February.

2. Failure to have adequate written procedures for testing components for conformance to specifications as required by 21 CFR 820.80(a). For example, the incoming inspection procedure ([purged word]) for components does not include testing procedures (or corresponding testing records) for EPROMS and circuit boards (w/EPROMS) used the Giotto [purged word] and [purged word] devices (e.g.: [purged word], [purged word] and [purged word] incoming components and EPROMS).

Your response may be adequate if verified by documentation showing implementation. Your response noted that a new procedure would be applied in March.

3a. Failure to establish and implement specification control measures to assure that the design basis for the devices is correctly translated into approved specifications, as required by 21 CFR 820.100(a)(1). For example, there are no records for the programming of EPROMS.

3b. Failure to maintain a record of component acceptance or rejection, as required by 21 CFR 820.80(a). For example, there are no records for the success/failure of the EPROM programming operation.

4. Failure of the device master record to be signed and dated by a designated individual(s), as required by 21 CFR 820.181. For example, the master and working copies of software for EPROMS used in Giotto [purged word] and [purged word] devices were not observed signed/dated as approved.

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.